Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Quest Strengthens Lab Services Segment with M&A
Medical Devices and Diagnostics Industry
Thu, 10/6/22 - 10:41 am
Quest Diagnostics
M&A
Summa Health
LabCare Plus
Pfizer’s dealmaking continues as GBT, Biohaven acquisitions close
Medical Marketing and Media
Wed, 10/5/22 - 10:43 am
Pfizer
M&A
Global Blood Therapeutics
Biohaven
No big bang for biopharma buyouts
EP Vantage
Wed, 10/5/22 - 10:29 am
M&A
Pfizer
Global Blood Therapeutics
Amgen
ChemoCentryx
Novo Nordisk
Forma
Alcon
Aerie Pharmaceuticals
Gilead Sciences
MiroBio
AstraZeneca pays 666% premium to buy genomic medicine biotech
Fierce Biotech
Mon, 10/3/22 - 10:26 am
AstraZeneca
M&A
Alexion
LogicBio Therapeutics
genomic medicine
Sumitomo Offers to Buy All of Myovant in $2.5 Billion Deal
Yahoo/Bloomberg
Mon, 10/3/22 - 10:24 am
Sumitomo Pharma
M&A
Myovant
Incyte pays out $70M to get hands on Medicxi-backed vitiligo biotech
Endpoints
Mon, 10/3/22 - 10:21 am
Incyte
M&A
Villaris Therapeutics
vitiligo
Medicxi
Solid Bio hopes to fortify itself after fusing with AavantiBio, but not before axing its lead asset
Fierce Biotech
Fri, 09/30/22 - 10:58 am
Solid Biosciences
M&A
gene therapy
AavantiBio
As lead drug flopped and AbbVie collab dissolved, cancer biotech resorts to buying rare disease company
Endpoints
Thu, 09/29/22 - 10:02 am
Idera Pharmaceuticals
AbbVie
Aceragen
M&A
CVS Is in Another Bidding War
Motley Fool
Thu, 09/29/22 - 09:46 am
CVS Health
Cano Health
M&A
Bay State biotechs Sesen and Carisma blend together in bid to transform cancer treatment
Fierce Biotech
Wed, 09/21/22 - 07:57 pm
Sensen Bio
Carisma Therapeutics
M&A
macrophages
Gilead completes acquisition of MiroBio in $405m cash deal
PM Live
Wed, 09/21/22 - 10:29 am
Gilead Sciences
M&A
MiroBio
autoimmune disease
Rocket inks Renovacor buyout to propel its heart disease gene therapy ambitions
Fierce Biotech
Tue, 09/20/22 - 10:37 am
Rocket Pharmaceuticals
M&A
gene therapy
Renovacor
heart disease
Seagen secures a speedy FDA review on Tukysa as Merck buyout talks reportedly stall
Endpoints
Mon, 09/19/22 - 10:02 pm
Seagen
Merck
M&A
Tukysa
With $100M, Galvanize Absorbs Two Biotechs to Advance Electric Pulse Therapies
BioSpace
Thu, 09/15/22 - 11:14 pm
pulse therapy
funding
Galvanize Therapeutics
M&A
Gala Therapeutics
Galaxy Medical
Is CVS' Acquisition of Signify in Danger of Falling Through?
Motley Fool
Thu, 09/15/22 - 10:32 am
CVS
Signify Health
M&A
antitrust
Medtronic signs development deal with surgical robot-maker Titan Medical
Medtech Dive
Wed, 09/14/22 - 09:37 am
Medtech
devices
M&A
Medtronic
Titan Medical
robotic surgery
With first drug on the market, Arcutis forks over $16M cash for a buyout
Endpoints
Thu, 09/8/22 - 10:56 am
M&A
Arcutis Biotherapeutics
Ducentis BioTherapeutics
Illumina’s hold on Grail depends now on separate appeals in US, Europe
BioSpace
Thu, 09/8/22 - 10:43 am
Illumina
Grail
M&A
Europe
RxMx and Curatio Announce Merger to Tackle Urgent Healthcare Gaps
CP Wire
Wed, 09/7/22 - 12:34 pm
RxMx
Curatio
M&A
digital health
RxPx
patients
RxMx and Curatio Announce Merger to Tackle Urgent Healthcare Gaps
Wed, 09/7/22 - 12:31 pm
RxMx
Curatio
M&A
digital health
RxPx
patients
Pages
« first
‹ previous
…
24
25
26
27
28
29
30
31
32
…
next ›
last »